Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2017 (2017), Article ID 9478958, 9 pages
https://doi.org/10.1155/2017/9478958
Research Article

The Protective Effect of Naringenin-Oxime on Cisplatin-Induced Toxicity in Rats

1Department of Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey
2Department of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey
3Department of Urology, Faculty of Medicine, Harran University, Sanliurfa, Turkey
4Department of Chemistry, Faculty of Science and Literature, Harran University, Sanliurfa, Turkey

Correspondence should be addressed to Ismail Koyuncu; moc.liamg@1ucnuyokliamsi

Received 12 May 2017; Accepted 19 July 2017; Published 28 August 2017

Academic Editor: Tzi Bun Ng

Copyright © 2017 Ismail Koyuncu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Ma, L. Yan, Q. Zhu, F. Shao, and P. Mukhopadhyay, “Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway,” PLOS ONE, vol. 12, no. 2, p. e0171612, 2017. View at Publisher · View at Google Scholar
  2. M. S. Sanatani, A. Lazo-Langner, and I. M. Al-Rasheedy, “Cisplatin and short-term 5-fluorouracil infusion for paraneoplastic microangiopathic hemolytic anemia in gastric cancer: a case report and review of the literature,” Case Reports in Oncological Medicine, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  3. H. Hagar, A. El Medany, R. Salam, G. El Medany, and O. A. Nayal, “Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats,” Experimental and Toxicologic Pathology, vol. 67, no. 2, pp. 133–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Pan, K. Shen, X. Wang, H. Meng, C. Wang, and B. Jin, “Protective effect of metalloporphyrins against Cisplatin-induced kidney injury in mice,” PLoS ONE, vol. 9, no. 1, Article ID e86057, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. B. D. Sahu, S. Tatireddy, M. Koneru et al., “Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection,” Toxicology and Applied Pharmacology, vol. 277, no. 1, pp. 8–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. K. A.-G. Mohamed and A. A, “Silymarin administration protects against cisplatin-induced nephrotoxicity in adult male albino rats. (Histological and Immunohistochemical Study),” Egyptian Journal of Histology, vol. 33, pp. 683–691, 2010. View at Google Scholar
  7. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent, “Cisplatin nephrotoxicity: a review,” The American Journal of the Medical Sciences, vol. 334, no. 2, pp. 115–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Coskun, M. T. Hatipoglu, C. Ozogul et al., “The protective effects of acetyl L-carnitine on testis gonadotoxicity induced by cisplatin in rats,” Balkan Medical Journal, vol. 30, no. 2, pp. 235–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Topcu-Tarladacalisir, M. Sapmaz-Metin, and T. Karaca, “Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis,” Renal Failure, vol. 38, no. 10, pp. 1741–1748, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ishikawa, Y. Takayanagi, and K. Sasaki, “Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice,” Research Communications in Chemical Pathology and Pharmacology, vol. 67, pp. 131–141, 1990. View at Google Scholar
  11. B. D. Sahu, M. Kuncha, G. J. Sindhura, and R. Sistla, “Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage,” Phytomedicine, vol. 20, no. 5, pp. 453–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. I. Chirino and J. Pedraza-Chaverri, “Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity,” Experimental and Toxicologic Pathology, vol. 61, no. 3, pp. 223–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Sadzuka, Y. Shimizu, and Y. Takino, “Role of glutathione S-transferase isoenzymes in cisplatin-induced nephrotoxicity in the rat,” Toxicology Letters, vol. 70, pp. 211–22, 1994. View at Google Scholar
  14. A. Basu and S. Krishnamurthy, “Cellular responses to cisplatin-induced DNA damage,” Journal of Nucleic Acids, vol. 2010, Article ID 201367, 16 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. E. M. Vickers, K. Rose, R. Fisher, M. Saulnier, P. Sahota, and P. Bentley, “Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology,” Toxicologic Pathology, vol. 32, no. 5, pp. 577–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Krüger, J. Thomale, N. Stojanović et al., “Platinum-induced kidney damage: unraveling the DNA damage response (DDR) of renal tubular epithelial and glomerular endothelial cells following platinum injury,” Biochimica et Biophysica Acta - Molecular Cell Research, vol. 1853, no. 3, pp. 685–698, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. G. C. Dos Santos, L. M. Mendonça, G. A. Antonucci, A. C. dos Santos, L. M. G. Antunes, and M. D. L. P. Bianchi, “Protective effect of bixin on cisplatin-induced genotoxicity in PC12 cells,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 335–340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. A. Arivarasu, S. Priyamvada, and R. Mahmood, “Oral administration of caffeic acid ameliorates the effect of cisplatin on brush border membrane enzymes and antioxidant system in rat intestine,” Experimental and Toxicologic Pathology, vol. 65, no. 1-2, pp. 21–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Leonetti, A. Biroccio, C. Gabellini et al., “α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy,” International Journal of Cancer, vol. 104, no. 2, pp. 243–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Özkol, D. Musa, Y. Tuluce, and I. Koyuncu, “Ameliorative influence of Urtica dioica L against cisplatin-induced toxicity in mice bearing Ehrlich ascites carcinoma,” Drug and Chemical Toxicology, vol. 35, no. 3, pp. 251–257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Wozniak, A. Czechowska, and J. Blasiak, “Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571,” Chemico-Biological Interactions, vol. 147, no. 3, pp. 309–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, and M. Yano, “Quantitation of flavonoid constituents in citrus fruits,” Journal of Agricultural and Food Chemistry, vol. 47, no. 9, pp. 3565–3571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Felgines, O. Texier, C. Morand et al., “Bioavailability of the flavanone naringenin and its glycosides in rats,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 279, no. 6, pp. G1148–G1154, 2000. View at Google Scholar · View at Scopus
  24. J. H. Lee and G. H. Kim, “Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis,” Journal of Food Science, vol. 75, no. 7, pp. H212–H217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Miyake, K. Minato, S. Fukumoto et al., “New potent antioxidative hydroxyflavanones produced with aspergillus saitoi from flavanone glycoside in citrus fruit,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 7, pp. 1443–1450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Arul and P. Subramanian, “Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells,” Pathology and Oncology Research, vol. 19, no. 4, pp. 763–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Chanet, D. Milenkovic, C. Deval et al., “Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice,” The Journal of Nutritional Biochemistry, vol. 23, no. 5, pp. 469–477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Raza, M. M. Khan, A. Ahmad et al., “Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke,” Neuroscience, vol. 230, pp. 157–171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Özyürek, D. Akpinar, M. Bener, B. Türkkan, K. Güçlü, and R. Apak, “Novel oxime based flavanone, naringin-oxime: Synthesis, characterization and screening for antioxidant activity,” Chemico-Biological Interactions, vol. 212, no. 1, pp. 40–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Türkkan, M. Özyürek, M. Bener, K. Güçlü, and R. Apak, “Synthesis, characterization and antioxidant capacity of naringenin-oxime,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 85, no. 1, pp. 235–240, 2012. View at Publisher · View at Google Scholar
  31. A. Kocyigit, I. Koyuncu, A. Taskin, M. Dikilitas, F. Bahadori, and B. Turkkan, “Antigenotoxic and antioxidant potentials of newly derivatized compound naringenin-oxime relative to naringenin on human mononuclear cells,” Drug and Chemical Toxicology, vol. 39, no. 1, pp. 66–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Kanďár and N. Hájková, “Assay of total glutathione and glutathione disulphide in seminal plasma of male partners of couples presenting for a fertility evaluation,” Andrologia, vol. 46, no. 10, pp. 1079–1088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–11111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Harma, A. Kocyigit, and O. Erel, “Increased DNA damage in patients with complete hydatidiform mole,” Swiss Medical Weekly, vol. 583, no. 1, pp. 49–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. B. H. Ali and M. S. Al Moundhri, “Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research,” Food and Chemical Toxicology, vol. 44, no. 8, pp. 1173–1183, 2006. View at Publisher · View at Google Scholar
  38. S. Hosseinian, A. Khajavi Rad, M.-A.-R. Hadjzadeh, N. Mohamadian Roshan, S. Havakhah, and S. Shafiee, “The protective effect of Nigella sativa against cisplatin-induced nephrotoxicity in rats,” Avicenna Journal of Phytomedicine, vol. 6, pp. 44–54, 2016. View at Google Scholar
  39. G. R. Davies, N. J. Simmonds, T. R. J. Stevens, A. Grandison, D. R. Blake, and D. S. Rampton, “Mucosal reactive oxygen metabolite production in duodenal ulcer disease,” Gut, vol. 33, no. 11, pp. 1467–1472, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. S. Karafakıoğlu, M. F. Bozkurt, Ö. Hazman, and A. F. Fıdan, “Efficacy of safranal to cisplatin-induced nephrotoxicity,” Biochemical Journal, vol. 474, no. 7, pp. 1195–1203, 2017. View at Publisher · View at Google Scholar
  41. I. Kelle, H. Akkoc, S. Tunik, Y. Nergiz, M. Erdinc, and L. Erdinc, “Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity,” Biotechnology and Biotechnological Equipment, vol. 28, no. 4, pp. 674–680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Fujikawa, M. Kawanishi, I. Kuraoka, and T. Yagi, “Frequencies of mutagenic translesion DNA synthesis over cisplatin-guanine intra-strand crosslinks in lacZ plasmids propagated in human cells,” Mutation Research - Genetic Toxicology and Environmental Mutagenesis, vol. 770, pp. 23–28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J. W. Hill, J. J. Hu, and M. K. Evans, “OGG1 is degraded by calpain following oxidative stress and cisplatin exposure,” DNA Repair, vol. 7, no. 4, pp. 648–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Kodama, H. Watanabe, R. Tanaka et al., “Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity,” Biochimica et Biophysica Acta - General Subjects, vol. 1840, no. 3, pp. 1152–1162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Cadet, T. Douki, D. Gasparutto, and J.-L. Ravanat, “Oxidative damage to DNA: formation, measurement and biochemical features,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 531, no. 1-2, pp. 5–23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Stepniak and M. Karbownik-Lewinska, “17 β-estradiol prevents experimentally-induced oxidative damage to membrane lipids and nuclear DNA in porcine ovary,” Systems Biology in Reproductive Medicine, vol. 62, no. 1, pp. 17–21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Cadet, “Oxidative degradation pathways of cellular DNA: product formation and mechanistic insights,” Free Radical Biology and Medicine, vol. 75, p. S2, 2014. View at Publisher · View at Google Scholar
  48. D. Altuner, M. Gulaboglu, O. E. Yapca, and N. Cetin, “The effect of mirtazapine on cisplatin-induced oxidative damage and infertility in rat ovaries,” The Scientific World Journal, vol. 2013, Article ID 327240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ince, D. Arslan Acaroz, O. Neuwirth et al., “Protective effect of polydatin, a natural precursor of resveratrol, against cisplatin-induced toxicity in rats,” Food and Chemical Toxicology, vol. 72, pp. 147–153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. A. M. Soliman, S. Desouky, M. Marzouk, and A. A. Sayed, “Origanum majorana attenuates nephrotoxicity of cisplatin anticancer drug through ameliorating oxidative stress,” Nutrients, vol. 8, no. 5, article no. 264, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. M. I. Yousef, A. A. Saad, and L. K. El-Shennawy, “Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats,” Food and Chemical Toxicology, vol. 47, no. 6, pp. 1176–1183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. R. O. Recknagel, E. A. Glende Jr., J. A. Dolak, and R. L. Waller, “Mechanisms of carbon tetrachloride toxicity,” Pharmacology and Therapeutics, vol. 43, no. 1, pp. 139–154, 1989. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Bakır, Ü. C. Yazgan, I. İbiloğlu, B. Elbey, M. Kızıl, and M. Kelle, “The protective effect of pomegranate extract against cisplatin toxicity in rat liver and kidney tissue,” Archives of Physiology and Biochemistry, vol. 121, no. 4, pp. 152–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. U. Kilic, E. Kilic, Z. Tuzcu et al., “Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway,” Nutrition & Metabolism, p. 7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, “Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker,” Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206–209, 1982. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Goswami, D. Tayal, N. Gupta, and V. Mallika, “Paraoxonase: a multifaceted biomolecule,” Clinica Chimica Acta, vol. 410, no. 1-2, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Trudel, D. Sinnett, R. W. James et al., “Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats,” Journal of Cellular Biochemistry, vol. 96, no. 2, pp. 404–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. M. C. Gonzalvo, F. Gil, A. F. Hernandez, L. Rodrigo, E. Villanueva, and A. Pla, “Human liver paraoxonase (PON1): subcellular distribution and characterization,” Journal of Biochemical and Molecular Toxicology, vol. 12, no. 1, pp. 61–69, 1998. View at Publisher · View at Google Scholar · View at Scopus